Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-12-31: Form 6-K; Period of report 2020-12-30; Description 6-K; Document d101015d6k.htm.
- 2020-12-30: Form 6-K; Period of report 2020-12-30; Description 6-K; Document d95731d6k.htm.
- 2020-12-14: Form 6-K; Period of report 2020-12-14; Description 6-K; Document d56991d6k.htm.
- 2020-12-11: Form 6-K; Period of report 2020-12-11; Description 6-K; Document d28560d6k.htm.